Assessment of periodic screening of women with denser breast using WBUS and DBT
Assessment of periodic screening of women with denser breast using WBUS and DBT
批准号:
9066603
负责人:
Wendie A Berg
金额:
$60.9万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-01 至 2020-05-31
关键词:
AddressAgeArbitrationAreaAxillary lymph node groupBenignBiopsyBreastBreast Cancer DetectionBreast Cancer Early DetectionCancer DetectionClinicClinicalConsentDecision MakingDetectionDevelopmentDiagnosisDiagnosticDigital Breast TomosynthesisDuctalERBB2 geneEnvironmentEpidermal Growth Factor ReceptorEquilibriumEstrogen ReceptorsHandHealthHumanImageImaging TechniquesInformation SystemsInjection of therapeutic agentInstitutional Review BoardsInvestigationLobularMagnetic Resonance ImagingMalignant NeoplasmsMammary Gland ParenchymaMammographic screeningMammographyModalityNoninfiltrating Intraductal CarcinomaParticipantPerformancePlayPopulationPositioning AttributePredictive ValueProceduresProgesteroneProspective StudiesProtocols documentationRadioactiveReaderRecommendationRecruitment ActivityReportingResearch ActivityResearch DesignRiskRisk FactorsRoleS-Phase FractionScheduleScreening procedureServicesSiteStagingStressTechnologyTestingTimeTrainingUltrasonographyWomanWorkbasebreast densitybreast imagingcancer typeclinical practicecomparative effectivenesscone-beam computed tomographycostdensityerbB-2 Receptorexperiencefollow-upimaging modalityimprovedinterestmalignant breast neoplasmmolecular imagingnew technologypersonalized approachprogramsradiologistreceptorscreeningtumoryoung woman
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The continuing controversy regarding the efficacy of, and optimal individualized approaches to, screening for the early detection of breast cancer, including the argument that conventional / traditional screening approaches may result in the detection of many cancers that are not likely to ultimately impact survival, stresses the importance of investigating alternative approaches to screening, in particular as related to younger women and / or women with denser than average age adjusted breast tissue who are at an elevated risk for developing breast cancer and in whom conventional mammography is known to be quite limited. Recent initiatives in many states require notifying women of their breast density. Women recommended for additional imaging (i.e., density BIRADS 3 and 4) constitutes between 40 and 50 percent of the screened population. The two possible high volume procedures being considered for this purpose are Whole Breast Ultrasound (WBUS) performed either manually or automatically and Digital Breast Tomosynthesis (DBT) that is being incorporated in routine clinical practice. Both DBT and WBUS technologies have advantages and limitations. To date, significant questions remain regarding the role that either may ultimately play in screening based breast imaging. As important, questions remain as to the marginal value of supplementary WBUS in a DBT based practice when DBT rather than FFDM is used as the baseline procedure. Therefore, at this time, it is important to validate / confirm te demonstrated potential for an acceptable performance for each of these modalities, as well as a significant performance improvement when using these approaches jointly and compare these performance levels, not only in terms of cancer detection and recall rates, but also in terms of the types of cancers likely to be detected by each imaging modality. As important, we will also assess experimentally the marginal value of WBUS as a supplementary imaging procedure to DBT based screening. The purpose of this project is to address these very issues by performing a prospective study on women who are most likely to benefit from the use of either WBUS and/or DBT or both in the screening environment. We propose to assess these questions in a sequentially selected population of consenting women participating in our screening program, which will include four of our 12 busiest sites encompassing both private and academic clinics and will involve 12 of our "better performing" 28 breast imaging radiologists with a wide range of experience levels and practice parameters. This project has broad and potentially significant implications on breast imaging as a whole. We have been collaborating as an integrated team in all scientific, operational, and clinical aspects of breast imaging, including, but not limited to,
DBT and WBUS. The proposed project represents a natural, timely and warranted continuation and expansion of our ongoing investigations in this extremely important area of imaging based screening for the early detection of breast cancer, particularly those cancers that are unlikely to
represent "over-diagnosis".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessment of periodic screening of women with denser breast using WBUS and DBT
-
批准号:8875927
-
项目类别:
-
资助金额:$60.9万
-
财政年份:2015
-
负责人:Wendie A Berg
-
依托单位:
Assessment of periodic screening of women with denser breast using WBUS and DBT
-
批准号:9487687
-
项目类别:
-
资助金额:$60.9万
-
财政年份:2015
-
负责人:Wendie A Berg
-
依托单位:
Assessment of periodic screening of women with denser breast using WBUS and DBT
-
批准号:9266757
-
项目类别:
-
资助金额:$71.01万
-
财政年份:2015
-
负责人:Wendie A Berg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: